UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells

The Journal of biological chemistry, 1998-09, Vol.273 (36), p.23419-23425

1998

Volltextzugriff (PDF)

Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne’s syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues

Biochemical pharmacology, 2000-12, Vol.60 (11), p.1611-1619

2000

Volltextzugriff (PDF)

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

The Journal of clinical investigation, 1994-08, Vol.94 (2), p.703-708

1994

Volltextzugriff (PDF)

Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells

Anticancer research, 2000-03, Vol.20 (2A), p.645

2000

Volltextzugriff (PDF)

Clinical pharmacology of cyclophosphamide

Cancer research (Chicago, Ill.), 1973-02, Vol.33 (2), p.226

1973

Volltextzugriff (PDF)

ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer Patients

JNCI : Journal of the National Cancer Institute, 1992-10, Vol.84 (19), p.1512-1517

1992

Volltextzugriff (PDF)

Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain

Molecular carcinogenesis, 1996-09, Vol.17 (1), p.1-7

1996

Volltextzugriff (PDF)

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

The Journal of clinical investigation, 1991-03, Vol.87 (3), p.772-777

1991

Volltextzugriff (PDF)

A Phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction

Clinical cancer research, 2001-06, Vol.7 (6), p.1600-1609

2001

Volltextzugriff (PDF)

A Phase I Trial of Carboxyamido-triazole and Paclitaxel for Relapsed Solid Tumors

Clinical cancer research, 2001-06, Vol.7 (6), p.1600

2001

Volltextzugriff (PDF)

Modulation of excision repair cross complementation group 1 (ercc-1) mrna expression by pharmacological agents in human ovarian carcinoma cells

Biochemical pharmacology, 1999-02, Vol.57 (4), p.347-353

1999

Volltextzugriff (PDF)

Brief Communication: Adriamycin-Induced Cardiac Damage in the Mouse: A Small-Animal Model of Cardiotoxicity

JNCI : Journal of the National Cancer Institute, 1975-07, Vol.55 (1), p.191-194

1975

Volltextzugriff (PDF)

Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells

International journal of oncology, 1998-11, Vol.13 (5), p.987

1998

Volltextzugriff (PDF)

Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues

Cancer letters, 2000-04, Vol.151 (2), p.127-132

2000

Volltextzugriff (PDF)

A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues

Mutation research, 1997-09, Vol.382 (1-2), p.13-20

1997

Volltextzugriff (PDF)

Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line

Anticancer research, 1998-07, Vol.18 (4A), p.2283

1998

Volltextzugriff (PDF)

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies

Cancer research (Chicago, Ill.), 1993-08, Vol.53 (16), p.3694-3699

1993

Volltextzugriff (PDF)

Deficient helper cell function as a cause of diminished pokeweed mitogen blastogenic responses in patients with non‐Hodgkin's lymphomas

Cancer, 1984-12, Vol.54 (12), p.2936-2942

1984

Volltextzugriff (PDF)

Increased Sensitivity to Normal Adherent Suppressor Cells in Untreated Advanced Hodgkin’s Disease

Blood, 1981-05, Vol.57 (5), p.830-835

1981

Volltextzugriff (PDF)

Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin

Cancer research (Chicago, Ill.), 1993-01, Vol.53 (2), p.242-247

1993

Volltextzugriff (PDF)

Suramin in advanced platinum-resistant ovarian cancer

European journal of cancer (1990), 1992, Vol.28 (4), p.864-866

1992

Volltextzugriff (PDF)

Alterations in DNA synthesis in cardiac tissue induced by adriamycin in vivo—Relationship to fatal toxicity

Biochemical pharmacology, 1975-10, Vol.24 (20), p.1898-1901

1975

Volltextzugriff (PDF)

Comparative analyses of relativeERCC3 andERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain

Molecular carcinogenesis, 1996-09, Vol.17 (1), p.1-7

1996

Volltextzugriff (PDF)

Ovarian cancer: A solid tumor with evidence of normal cellular immune function but abnormal B cell function

The American journal of medicine, 1979-04, Vol.66 (4), p.621-624

1979

Volltextzugriff (PDF)

Cisplatin-DNA Damage and Repair in Peripheral Blood Leukocytes in Vivo and in Vitro

Environmental health perspectives, 1992-11, Vol.98, p.53-59

1992

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells

Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne’s syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells

Clinical pharmacology of cyclophosphamide

ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer Patients

Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

A Phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: Potential efficacy of the combination and demonstration of pharmacokinetic interaction

A Phase I Trial of Carboxyamido-triazole and Paclitaxel for Relapsed Solid Tumors

Modulation of excision repair cross complementation group 1 (ercc-1) mrna expression by pharmacological agents in human ovarian carcinoma cells

Brief Communication: Adriamycin-Induced Cardiac Damage in the Mouse: A Small-Animal Model of Cardiotoxicity

Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells

Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues

A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues

Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies

Deficient helper cell function as a cause of diminished pokeweed mitogen blastogenic responses in patients with non‐Hodgkin's lymphomas

Increased Sensitivity to Normal Adherent Suppressor Cells in Untreated Advanced Hodgkin’s Disease

Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin

Suramin in advanced platinum-resistant ovarian cancer

Alterations in DNA synthesis in cardiac tissue induced by adriamycin in vivo—Relationship to fatal toxicity

Comparative analyses of relativeERCC3 andERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain

Ovarian cancer: A solid tumor with evidence of normal cellular immune function but abnormal B cell function

Cisplatin-DNA Damage and Repair in Peripheral Blood Leukocytes in Vivo and in Vitro

Suchergebnisse filtern